Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Treatment strategies for polycythemia vera: observations in a Dutch 'real world' cohort study.

van de Ree-Pellikaan C, de Kreuk A, Schaar CG, Beeker A, Dompeling EC, Gerrits CJH, van Houten AA, Schipperus MR, Strobbe L, Posthuma EFM, Klauke K, Westerweel PE.

Eur J Haematol. 2019 Jul 12. doi: 10.1111/ejh.13291. [Epub ahead of print]

PMID:
31298768
2.

Transition from fresh frozen plasma to solvent/detergent plasma in the Netherlands: comparing clinical use and transfusion reaction risks.

Saadah NH, Schipperus MR, Wiersum-Osselton JC, van Kraaij MG, Caram-Deelder C, Beckers EAM, Leyte A, Rondeel JMM, de Vooght KMK, Weerkamp F, Zwaginga JJ, van der Bom JG.

Haematologica. 2019 Jul 4. pii: haematol.2019.222083. doi: 10.3324/haematol.2019.222083. [Epub ahead of print]

3.

Updated definitions for respiratory complications of blood transfusion.

Schipperus MR, Wiersum-Osselton JC; ISBT-IHN-AABB TACO Definition Revision Group.

Transfusion. 2019 Jul;59(7):2482-2483. doi: 10.1111/trf.15389. No abstract available.

PMID:
31268594
4.

International haemovigilance: what have we learned and what do we need to do next?

Wood EM, Ang AL, Bisht A, Bolton-Maggs PH, Bokhorst AG, Flesland O, Land K, Wiersum-Osselton JC, Schipperus MR, Tiberghien P, Whitaker BI.

Transfus Med. 2019 Aug;29(4):221-230. doi: 10.1111/tme.12582. Epub 2019 Feb 6. Review.

PMID:
30729612
5.

Transfusion reactions after transfusion of platelets stored in PAS-B, PAS-C, or plasma: a nationwide comparison.

van Hout FMA, van der Meer PF, Wiersum-Osselton JC, Middelburg RA, Schipperus MR, van der Bom JG, Kerkhoffs JL.

Transfusion. 2018 Apr;58(4):1021-1027. doi: 10.1111/trf.14509. Epub 2018 Feb 6.

PMID:
29405304
6.

Comparing transfusion reaction risks for various plasma products - an analysis of 7 years of ISTARE haemovigilance data.

Saadah NH, van der Bom JG, Wiersum-Osselton JC, Richardson C, Middelburg RA, Politis C, Renaudier P, Robillard P, Schipperus MR.

Br J Haematol. 2018 Mar;180(5):727-734. doi: 10.1111/bjh.15082. Epub 2018 Jan 9.

PMID:
29318576
7.

Comparing transfusion reaction rates for various plasma types: a systematic review and meta-analysis/regression.

Saadah NH, van Hout FMA, Schipperus MR, le Cessie S, Middelburg RA, Wiersum-Osselton JC, van der Bom JG.

Transfusion. 2017 Sep;57(9):2104-2114. doi: 10.1111/trf.14245. Epub 2017 Aug 2. Review.

PMID:
28766723
8.

Effect of solvent/detergent-treated pooled plasma on fibrinolysis in reconstituted whole blood.

Saadah NH, van der Meer PF, Brinkman HJM, de Korte D, Bontekoe IJ, Korsten HH, Middelburg RA, van der Bom JG, Schipperus MR.

Transfusion. 2017 Oct;57(10):2381-2389. doi: 10.1111/trf.14260. Epub 2017 Jul 20.

PMID:
28727139
9.

Storage medium of platelet transfusions and the risk of transfusion-transmitted bacterial infections.

Kreuger AL, Middelburg RA, Kerkhoffs JH, Schipperus MR, Wiersum-Osselton JC, van der Bom JG.

Transfusion. 2017 Mar;57(3):657-660. doi: 10.1111/trf.13969. Epub 2017 Jan 31.

PMID:
28144957
10.

Successful treatment of a noninhibitory antibody-mediated acquired factor X deficiency in a patient with marginal-zone lymphoma.

Meenhuis A, van Vliet R, Hudig F, Ypma PF, Schipperus MR, Hollestelle MJ.

Clin Case Rep. 2015 Jul;3(7):587-93. doi: 10.1002/ccr3.294. Epub 2015 May 25.

11.

Quality indicators for the hospital transfusion chain: a national survey conducted in 100 dutch hospitals.

Zijlker-Jansen PY, Janssen MP, van Tilborgh-de Jong AJ, Schipperus MR, Wiersum-Osselton JC.

Vox Sang. 2015 Oct;109(3):287-95. doi: 10.1111/vox.12281. Epub 2015 Apr 20.

PMID:
25898854
12.

Presence of medication taken by blood donors in plasma for transfusion.

van Tilborgh-de Jong AJ, Wiersum-Osselton JC, Touw DJ, Schipperus MR.

Vox Sang. 2015 May;108(4):323-7. doi: 10.1111/vox.12230. Epub 2014 Dec 30.

PMID:
25557151
13.

Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients.

Zwaginga JJ, van der Holt B, Te Boekhorst PA, Biemond BJ, Levin MD, van der Griend R, Brand A, Zweegman S, Pruijt HF, Novotny VM, Vreugdenhil A, de Groot MR, de Weerdt O, van Pampus EC, van Maanen-Lamme TM, Wittebol S, Schipperus MR, Silbermann MH, Huijgens PC, Luten M, Hollestein R, Brakenhoff JA, Schrama JG, Valster FA, Velders GA, Koene HR; Dutch HOVON 64 study group.

Haematologica. 2015 Mar;100(3):e90-2. doi: 10.3324/haematol.2014.110213. Epub 2014 Nov 25. No abstract available.

14.

A phase 2, randomized, double-blind, multicenter study comparing siltuximab plus best supportive care (BSC) with placebo plus BSC in anemic patients with International Prognostic Scoring System low- or intermediate-1-risk myelodysplastic syndrome.

Garcia-Manero G, Gartenberg G, Steensma DP, Schipperus MR, Breems DA, de Paz R, Valcárcel D, Kranenburg B, Reddy M, Komrokji RS.

Am J Hematol. 2014 Sep;89(9):E156-62. doi: 10.1002/ajh.23780. Epub 2014 Jun 23.

15.

The efficiency of therapeutic erythrocytapheresis compared to phlebotomy: a mathematical tool for predicting response in hereditary hemochromatosis, polycythemia vera, and secondary erythrocytosis.

Evers D, Kerkhoffs JL, Van Egmond L, Schipperus MR, Wijermans PW.

J Clin Apher. 2014 Jun;29(3):133-8. doi: 10.1002/jca.21303. Epub 2013 Oct 15.

PMID:
24130064
16.

Helicobacter pylori infection is not correlated with subclinical thrombocytopenia: a cross-sectional study.

Samson AD, Schipperus MR, Langers AM, Dekkers OM.

Platelets. 2014;25(3):221-3. doi: 10.3109/09537104.2013.803063. Epub 2013 Jun 20.

PMID:
23786387
17.

Quality validation of data in national haemovigilance systems in Europe: report of a survey on current state of practice.

Wiersum-Osselton JC, Faber JC, Politis C, Brand A, van der Bom JG, Schipperus MR.

Vox Sang. 2013 Apr;104(3):214-7. doi: 10.1111/j.1423-0410.2012.01659.x. Epub 2012 Oct 13.

PMID:
23061879
18.

A novel chronic lymphocytic leukemia subset expressing mutated IGHV3-7-encoded rheumatoid factor B-cell receptors that are functionally proficient.

Hoogeboom R, Wormhoudt TA, Schipperus MR, Langerak AW, Dunn-Walters DK, Guikema JE, Bende RJ, van Noesel CJ.

Leukemia. 2013 Mar;27(3):738-40. doi: 10.1038/leu.2012.238. Epub 2012 Aug 20. No abstract available.

PMID:
22902363
19.

Variation between hospitals in rates of reported transfusion reactions: is a high reporting rate an indicator of safer transfusion?

Wiersum-Osselton JC, van Tilborgh-de Jong AJ, Zijlker-Jansen PY, van de Watering LM, Brand A, van der Bom JG, Schipperus MR.

Vox Sang. 2013 Feb;104(2):127-34. doi: 10.1111/j.1423-0410.2012.01642.x. Epub 2012 Aug 15.

PMID:
22892067
20.

Allo-exposure status and leucocyte antibody positivity of blood donors show a similar relation with TRALI.

Middelburg RA, Beckers EA, Porcelijn L, Lardy N, Wiersum-Osselton JC, Schipperus MR, Vrielink H, Briët E, van der Bom JG.

Transfus Med. 2012 Apr;22(2):128-32. doi: 10.1111/j.1365-3148.2012.01140.x. Epub 2012 Mar 1.

PMID:
22380759
21.

Treatment of primary autoimmune thrombocytopenia (AITP) [1].

Schipperus MR, Fijnheer R, Pabinger I, Godeau B, Michel M, Tomiyama Y, Imbach P, Cuker A, Cines B, Panzer S, Reesink HW.

Vox Sang. 2012 Apr;102(3):261-8. doi: 10.1111/j.1423-0410.2011.1552.x. Epub 2011 Nov 4. No abstract available.

PMID:
22050204
22.

Storage time of blood products and transfusion-related acute lung injury.

Middelburg RA, Borkent-Raven BA, Janssen MP, van de Watering LM, Wiersum-Osselton JC, Schipperus MR, Beckers EA, Briët E, van der Bom JG.

Transfusion. 2012 Mar;52(3):658-67. doi: 10.1111/j.1537-2995.2011.03352.x. Epub 2011 Sep 26. Erratum in: Transfusion. 2012 Jun;52(6):1386. Borkent, Barbara [corrected to Borkent-Raven, Barbara A]; Jansen, Mart [corrected to Janssen, Mart P].

PMID:
21950582
23.

Male-only fresh-frozen plasma for transfusion-related acute lung injury prevention: before-and-after comparative cohort study.

Wiersum-Osselton JC, Middelburg RA, Beckers EA, van Tilborgh AJ, Zijlker-Jansen PY, Brand A, van der Bom JG, Schipperus MR.

Transfusion. 2011 Jun;51(6):1278-83. doi: 10.1111/j.1537-2995.2010.02969.x. Epub 2010 Dec 6.

PMID:
21133929
24.

Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction.

Kerkhoffs JL, van Putten WL, Novotny VM, Te Boekhorst PA, Schipperus MR, Zwaginga JJ, van Pampus LC, de Greef GE, Luten M, Huijgens PC, Brand A, van Rhenen DJ; Dutch - Belgian HOVON cooperative group.

Br J Haematol. 2010 Jul;150(2):209-17. doi: 10.1111/j.1365-2141.2010.08227.x. Epub 2010 May 9.

PMID:
20507310
25.

Haemovigilance for the optimal use of blood products in the hospital.

Reesink HW, Panzer S, Gonzalez CA, Lena N, Muntaabski P, Gimbatti S, Wood E, Lambermont M, Deneys V, Sondag D, Alport T, Towns D, Devine D, Turek P, Auvinen MK, Koski T, Lin CK, Lee CK, Tsoi WC, Lawlor E, Grazzini G, Piccinini V, Catalano L, Pupella S, Kato H, Takamoto S, Okazaki H, Hamaguchi I, Wiersum-Osselton JC, Van Tilborgh AJ, Zijlker-Jansen PY, Mangundap KM, Schipperus MR, Dinesh D, Flanagan P, Flesland Ø, Steinsvåg CT, Espinosa A, Letowska M, Rosiek A, Antoniewicz-Papis J, Lachert E, Koh MB, Alcantara R, Corral Alonso M, Muñiz-Diaz E.

Vox Sang. 2010 Oct;99(3):278-93. doi: 10.1111/j.1423-0410.2010.01323.x. No abstract available.

PMID:
20345518
26.

Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials.

George JN, Mathias SD, Go RS, Guo M, Henry DH, Lyons R, Redner RL, Rice L, Schipperus MR.

Br J Haematol. 2009 Feb;144(3):409-15. doi: 10.1111/j.1365-2141.2008.07464.x. Epub 2008 Nov 11.

PMID:
19016720
27.

[Transfusion-related acute lung injury (TRALI) in the Netherlands in 2002-2005].

Wiersum-Osselton JC, Porcelijn L, van Stein D, Vlaar AP, Beckers EA, Schipperus MR.

Ned Tijdschr Geneeskd. 2008 Aug 9;152(32):1784-8. Dutch.

PMID:
18754313
28.

Duration of meconium passage in preterm and term infants.

Bekkali N, Hamers SL, Schipperus MR, Reitsma JB, Valerio PG, Van Toledo L, Benninga MA.

Arch Dis Child Fetal Neonatal Ed. 2008 Sep;93(5):F376-9. doi: 10.1136/adc.2008.138024. Epub 2008 Feb 19.

PMID:
18285377
29.

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.

Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, Aledort LM, George JN, Kessler CM, Sanz MA, Liebman HA, Slovick FT, de Wolf JT, Bourgeois E, Guthrie TH Jr, Newland A, Wasser JS, Hamburg SI, Grande C, Lefrère F, Lichtin AE, Tarantino MD, Terebelo HR, Viallard JF, Cuevas FJ, Go RS, Henry DH, Redner RL, Rice L, Schipperus MR, Guo DM, Nichol JL.

Lancet. 2008 Feb 2;371(9610):395-403. doi: 10.1016/S0140-6736(08)60203-2.

PMID:
18242413
30.

Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands.

Laros-van Gorkom BA, Huisman CA, Wijermans PW, Schipperus MR.

Neth J Med. 2007 Oct;65(9):333-8.

31.

An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura.

Newland A, Caulier MT, Kappers-Klunne M, Schipperus MR, Lefrere F, Zwaginga JJ, Christal J, Chen CF, Nichol JL.

Br J Haematol. 2006 Nov;135(4):547-53.

PMID:
17061981
32.

Response to the international forum on haemovigilance.

Wiersum-Osselton JC, Schipperus MR.

Vox Sang. 2006 Oct;91(3):278-9. No abstract available.

PMID:
16958843
33.

T-lymphocyte reconstitution following rigorously T-cell-depleted versus unmodified autologous stem cell transplants.

Te Boekhorst PA, Lamers CH, Schipperus MR, Hintzen RQ, van der Holt B, Cornelissen JJ, Löwenberg B, Gratama JW.

Bone Marrow Transplant. 2006 Apr;37(8):763-72.

PMID:
16518423
34.

[Transfusion reactions in patients: haemovigilance reports to the Dutch National Haemovigilance Office in 2003].

Wiersum-Osselton JC, Schipperus MR.

Ned Tijdschr Geneeskd. 2005 Nov 19;149(47):2622-7. Dutch.

PMID:
16355575
35.

Feasibility of a restrictive red-cell transfusion policy for patients treated with intensive chemotherapy for acute myeloid leukaemia.

Jansen AJ, Caljouw MA, Hop WC, van Rhenen DJ, Schipperus MR.

Transfus Med. 2004 Feb;14(1):33-8.

PMID:
15043591
36.

Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study.

Hedenus M, Adriansson M, San Miguel J, Kramer MH, Schipperus MR, Juvonen E, Taylor K, Belch A, Altés A, Martinelli G, Watson D, Matcham J, Rossi G, Littlewood TJ; Darbepoetin Alfa 20000161 Study Group.

Br J Haematol. 2003 Aug;122(3):394-403.

PMID:
12877666
37.

Quality of life measurement in patients with transfusion-dependent myelodysplastic syndromes.

Jansen AJ, Essink-Bot ML, Beckers EA, Hop WC, Schipperus MR, Van Rhenen DJ.

Br J Haematol. 2003 Apr;121(2):270-4.

PMID:
12694248
38.

Stroma-supported progenitor production as a prognostic tool for graft failure following autologous stem cell transplantation.

Van Hennik PB, Breems DA, Kusadasi N, Slaper-Cortenbach IC, van den Berg H, van der Lelie HJ, Schipperus MR, Cornelissen JJ, Ploemacher RE.

Br J Haematol. 2000 Nov;111(2):674-84.

PMID:
11122121
39.

Diagnosis and treatment of portal vein thrombosis following splenectomy.

van't Riet M, Burger JW, van Muiswinkel JM, Kazemier G, Schipperus MR, Bonjer HJ.

Br J Surg. 2000 Sep;87(9):1229-33.

PMID:
10971433
40.

Coagulation factor levels in solvent/detergent-treated plasma.

Leebeek FW, Schipperus MR, van Vliet HH.

Transfusion. 1999 Oct;39(10):1150-1. No abstract available.

PMID:
10532612
41.

Interleukin-6 and interleukin-1 enhancement of GM-CSF-dependent proliferation of haematopoietic progenitor cells in myelodysplastic syndromes.

Schipperus MR, Sonneveld P, Lindemans J, van Lom K, Vlastuin M, Abels J.

Br J Haematol. 1991 Apr;77(4):515-22.

PMID:
2025577
42.

In vitro growth kinetics of myeloid progenitor cells of myelodysplastic patients in response to granulocyte-macrophage colony-stimulating factor and interleukin-3.

Schipperus MR, Vink N, Lindemans J, Hagemeijer A, Sonneveld P, Abels J.

Haematol Blood Transfus. 1990;33:98-102. No abstract available.

PMID:
2182468
43.

The combined effects of Il-3, GM-CSF and G-CSF on the in vitro growth of myelodysplastic myeloid progenitor cells.

Schipperus MR, Sonneveld P, Lindemans J, Vink N, Vlastuin M, Hagemeijer A, Abels J.

Leuk Res. 1990;14(11-12):1019-25.

PMID:
1704083
44.

In myelodysplastic syndromes progression to leukemia is directly related to PHA dependency for colony formation and independent of in vitro maturation capacity.

Schipperus MR, Hagemeijer A, Ploemacher RE, Lindemans J, Voerman JS, Abels J.

Leukemia. 1988 Jul;2(7):433-7.

PMID:
3393024

Supplemental Content

Loading ...
Support Center